1 year return (CAGR)
-95.67%
Psyence Biomedical Ltd. Common Shares Exchange (NASDAQ, USD)
PBM
5.40
+0.43 (+8.65%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-97.26%
5 year return (CAGR)
-
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
20.60M
Price/Sales
-
Ent value
14.34M
Price/Book
1.74
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 5.02 |
| Daily high | 5.63 |
| Daily low | 4.93 |
| Daily Volume | 130K |
| All-time high | 341015.63 |
| 1y analyst estimate | - |
| Beta | 1.67 |
| EPS (TTM) | -526.53 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| PBM | S&P500 | |
| Current price drop from All-time high | -100.00% | -1.75% |
| Highest price drop | -100.00% | -56.47% |
| Date of highest drop | 9 Apr 2026 | 9 Mar 2009 |
| Avg drop from high | -55.74% | -10.69% |
| Avg time to new high | 6 days | 12 days |
| Max time to new high | 702 days | 1805 days |
News
